Michel Alvarez - Chairman and Chief Executive Officer
Michel Alvarez is a veteran of the medical device industry overseeing successful product development, manufacturing, commercial launch, and business development activities. Mr. Alvarez has helped lead Healionics since its inception in 2007. He was promoted to CEO in 2009 following two years as COO and VP of Business Development. Mr. Alvarez has 18 years of experience as an entrepreneurial business executive in the information technology, consumer products, and medical device industries. He served 11 years in key roles including Vice President of Operations for dialysis device company Medisystems Corporation (acquired in 2007 by NxStage Medical – NXTM). Mr. Alvarez received a B.S. in International Management from SFSU and an MBA from the University of Washington.
Max Maginness, Ph.D. - President and Chief Operating Officer
Dr. Maginness has extensive experience in moving from concepts to robust, reliable and cost effective products in
both FDA–regulated and other industries. As co-founder of Healionics, Dr. Maginness has led the company’s
R&D efforts since inception. He has 30 years of experience in managing multiple new product development and technology
transfer projects for Siemens Medical, ATL (now Philips Ultrasound) and subsidiaries of CIBA-Geigy. These included complex multi-company and multinational projects in Europe, Japan, Korea and India. Earlier, Dr. Maginness held research positions at Stanford University and worked on technology development and business planning for startups.
Andrew Marshall, Ph.D. - Director and Chief Technology Officer
Dr. Marshall was named one of 40 Under 40
influential leaders and innovators shaping the MedTech industry by MD+DI magazine in 2012. As the co-inventor of Healionics' STAR biomaterial, he has over 12 years of experience working directly with this technology for improving biointegration of implantable medical devices, and he has been involved in test implant and device design for nearly 50 animal studies on STAR biomaterials. At the 3rd TERMIS World Congress 2012 in Vienna, Dr. Marshall was awarded the Innovation/Commercialization Award
"for the application of tissue engineering and regenerative medicine in the production of a product or technology that will ultimately benefit patients." He serves on Healionics' Board of Directors and on the Scientific Advisory Board for Healionics' Belgium-based ophthalmic device focused subsidiary, iSTAR Medical. And in 2011, he co-founded qSTAR Medical, Healionics' Paris-based subsidiary focused on dialysis access devices. He has held past positions as a medical device validation engineer for Kemper-Masterson, Inc. and as a design engineer for Boeing Defense and Space Group. He earned a PhD in Chemical Engineering from the University of Washington and a BSE in Biomechanical Engineering from Stanford University.
Arthur Coury, Ph.D. - Director
Back to top
Dr. Coury's has more than 40 years of expertise in the field of Biomaterials. He was recognized as one of "100 Notable People in the Medical Device Industry" by MD&DI magazine in 2008, and was elected to the National Academy of Engineering in 2009. Dr. Coury's broad experience in senior management roles include: Director, Polymer Technology (1988-1993) and Corporate Research Fellow (1983-1993) at Medtronic, Inc.; Vice President, Research (1993-2000) and Chief Scientific Officer (1998-2000) at Focal, Inc.; and Vice President, Biomaterials Research at Genzyme Corporation (2000-2008). Dr. Coury holds a B.S. degree in chemistry from the University of Delaware (1962), a Ph.D. in organic chemistry (1965) and an M.B.A. (1980) from the University of Minnesota.